Valo Health, Inc. ("Valo"), a pioneer in the use of human data and AI to accelerate drug discovery and development, today ...
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...
A study from Columbia University Mailman School of Public Health reports a major advance in understanding how interactions ...
Pharma commercial operating models rely on clinically testing many compounds to approve a single blockbuster that recoups all investments. The challenge for drug development is that clinical efficacy ...
BOSTON, Oct. 24, 2023 /PRNewswire/ -- PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in ...
Our foray into causal analysis is not yet complete. Until we define the methods of causal inference, we can't get to the deeper insights that causal analysis can provide. This article details many of ...
A study from Columbia University reports a major advance in understanding how interactions between human and viral genomes shape disease risk. The research found that variations in the Epstein–Barr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results